Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Hoosier Christians Outraged and Emboldened by Indiana's Secretive Death Penalty Plans


News provided by

Indianapolis First Friends

May 20, 2025, 13:30 ET

Share this article

Share toX

Share this article

Share toX


Indianapolis First Friends (a Quaker Meeting) strongly opposes the upcoming May 20 execution of Benjamin Ritchie, citing his mental disability and the lack of transparency surrounding the lethal drug Pentobarbital. They condemn Indiana's continued use of the death penalty and criticize state agencies for evading public records requests. The group urges faith communities to stand against capital punishment, calling the practice morally wrong and lacking in justice or accountability.

INDIANAPOLIS, May 20, 2025 /PRNewswire-PRWeb/ -- Indianapolis First Friends, A Quaker Meeting, not only expresses its deep and collective sadness over the upcoming execution of Benjamin Ritchie on May 20, but also its serious consternation over the veil of secrecy shrouding legitimate public information about the Pentobarbital to be used to take a human life that day.

"As Christians located in one of the shrinking number of states still implementing this barbaric practice, we are forced—unwillingly and without consultation or transparency—to witness and effectively participate in this abhorrent process," said Carolyn Tinsley, the Clerk of the Meeting.

This is about two wrongs making a larger wrong, and prioritizing killing over mercy and savagery over the rule of law will lead us neither to justice nor peace.

Post this

The testimony of Dr. Megan Carter, a forensic psychologist with expertise in fetal alcohol spectrum disorder (FASD), explained to Ritchie's clemency board on May 12 that she diagnosed Ritchie with partial FAS, highlighting that he has 15 of the 23 deficits of the disorder and struggles with emotional regulation, academics, social skills, and even speech.

"For the last 400 years, Friends have eschewed violence and advocated for peace. We abhor the violent murder of Officer Toney 25 years ago," said Bob Henry, Pastor at First Friends. "But returning that act of violence with more violence should not be done in our name, nor in the name of God our creator. This is about two wrongs making a larger wrong, and prioritizing killing over mercy and savagery over the rule of law will lead us neither to justice nor peace."

Since last October, First Friends has engaged various State agencies—including the former and current Governor's office and the Indiana Department of Correction—to obtain further information about the Pentobarbital used in Joseph Corocoran's execution on December 18, 2024. The Meeting resumed those requests when it became apparent that the State was likely to continue to obfuscate such details as contained in its most recent public records request under APRA on April 19, 2025 specifically:

[F]or any and all public records pertaining to: (1) whether the pentobarbital and/or other lethal injection substances used in December 2024—and/or intended for use in any upcoming executions—were compounded or manufactured; (2) the nation(s) in which such substances were compounded or manufactured; (3) the expiration dates of such substances; (4) the methods of storage of such substances; (5) any training on the use and administration of such substances; (6) the dosages of such substances used or intended for use in executions; (7) whether such substances were created, delivered, and/or regulated with intent for veterinary and/or human use; (8) the results of any testing on the purity, potency, and/or sterility of such substances; (9) the amount of such substances used by the State in December 2024; (10) the amount of such substances intended for use by the State in the next execution; (11) the percentages that the requests in (9) and (10) above represented (or are reasonably expected to represent) of the State's total supply on the following dates: December 1, 2024, December 31, 2024, May 1, 2025, and May 31, 2025; and (12) any inter- and intra-agency emails or other public records regarding how to handle public records requests pertaining to the use of such substances.

"We are aware that other organizations have made similar requests to our public agencies under our sunshine laws and have been similarly frustrated in their purposes," said Tinsley. "We are disappointed, but not terribly surprised, to have received silence so far from the Indiana Department of Correction and a functional non-response from the Governor's Office on May 6, which claimed in its entirety:

After reviewing your request, the Governor's Office has determined that we cannot move forward with your request as it is currently written. Please see below for an explanation and any suggested next steps. This agency does not maintain the records you have requested. Accordingly, we have completed our response and are closing our file at this time. Please reference the notes below to help locate the records responsive to your request. Please direct this request to the Department of Correction.

"These responses are not even on official letterhead under our new administration," noted Tinsley, "nor do we believe such cross finger-pointing gamesmanship satisfies either the spirit or intent of our state's open records laws. Nevertheless, we remain undeterred in our mission to understand how any aspects of our state's procurement of Pentobarbital to kill inmates is legitimate."

In a strongly worded letter from the European Union's Ambassador to the United States on December 13, 2024, Jovita Neliupšienė reminded former Governor Holcomb: "Although the European Union opposes the death penalty in all circumstances, we find it especially cruel to execute someone with severe mental illness. Moreover, it is a violation of international death penalty safeguards to carry out capital punishment on individuals with a psychosocial disability. If this execution is carried out, Indiana will join a small group of outlier states that rely on this inhumane and degrading punishment. The EU strongly opposes the death penalty at all times and in all circumstances. It is a violation of the right to life and fails to act as a deterrent to crime. It represents the ultimate punishment that makes miscarriages of justice irreversible."

According to Pastor Henry, "here we stand again today, not five months later, facing a state-sponsored killing machine that we are not permitted—either as taxpayers or people of faith—to ask questions about let alone understand. We call upon our friends across other Christian and non-Christian communities alike to stand against this and future executions. In particular, we thank our Catholic Friends, as well as our midwestern Pope, for taking commitments to the life of prisoners seriously. Perhaps the Statehouse could learn a lesson about consistency from the Vatican, as this is a dark day indeed for transparency and good governance in Indiana."

Media Contact

Indianapolis First Friends, Indianapolis First Friends, 1 3172552485, [email protected], www.indyfriends.org 

SOURCE Indianapolis First Friends

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.